• India’s nutraceuticals market grew at 22 percent annually during the Covid-19 pandemic.  Through 2030 the average annual growth rate is expected to hover around 16 perecent
  • India, currently a net importer of nutraceuticals, esp. from the USA, has started manufacturing and exporting many supplements. With middle-class Indian consumers unable to meet their nutritional needs through a typical carbohydrate-heavy Indian direct, they are increasingly understanding the value of nutritional supplements to bridge nutritional gaps.
  • The Indian people have started to trust immune-boosting supplements, which has resulted in a dramatic shift in purchasing habits and market behavior.  Sales of vitamin capsules, chewable pills, and adult gummies  are all rising

Many consumers are increasingly turning to nutraceutical supplements as a prophylactic to avert ailments or infections. These consumers includeg nutraceuticals into their regular daily lifetime regimen.  Some of this trend is driven by concerns around chemical drugs and by increasing anti-biotic resistance in India.

The Indian Nutraceutical Landscape

Vitamin supplements lead the Indian dietary supplement industry.

The Indian dietary supplements market is fragmented with the presence of several small and large players competing in terms of price and quality. Both foreign and domestic companies have a place in the Indian ecosystem Some of the major multinational players in the market are:

  • Abbott India Limited
  • Amway India Enterprises Private Limited
  • Danone Nutricia International Private Limited
  • Glanbia
  • GlaxoSmithKline Consumer Healthcare Limited
  • Herbalife International India Private Limited
  • Sanofi Aventis
  • Suisse

Indian companies with strong nutraceutical offerings include

  • Dabur India Limited
  • Himalaya Drug Company
  • Patanjali Ayurved Limited
  • Sun Pharmaceutical Industries Limited

The Government of India has permitted 100 percent FDI in this manufacturing sector under the automatic route, and such businesses may sell their products via wholesale, retail, or e-commerce platforms. Foreign Direct Investment (FDI) has risen from $131.4 million in 2012 to $584.7 million in 2019 evident from the rise of many American firms in India.To encourage new entrepreneurs in the nutraceutical area, the Food Safety and Norms Authority of India (FSSAI) is set to implement laws for nutraceuticals in India that are following worldwide standards. Once these policies are in place, they will open the door to  significant foreign investment.